Safety and efficacy of newer biologics DMARDs in the management of rheumatoid arthritis: A systematic review
{{output}}
Objective: To analyze the safety and efficacy of certain biologics DMARDs (Adalimumab, Baricitinib, Pefacitinib and Sirukumab) either used alone or as a combination with MTX for management of rheumatoid arthritis. ... ...
